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Abstract: Excessive calcium is thought to be a critical step in various neurodegenerative processes including ischemia. 
Calbindin D28k (CB), calretinin (CR), and parvalbumin (PV), members of the EF-hand calcium-binding protein family, are 
thought to play a neuroprotective role in various pathologic conditions by serving as a buffer against excessive calcium. The 
expression of CB, PV and CR in the ischemic rat retina induced by increasing intraocular pressure was investigated at the 
transcript and protein levels, by means of the quantitative real-time reverse transcription-polymerase chain reaction, western 
blot and immunohistochemistry. The transcript and protein levels of CB, which is strongly expressed in the horizontal cells in 
both normal and affected retinas, were not changed significantly and the number of CB-expressing horizontal cells remained 
unchanged throughout the experimental period 8 weeks after ischemia/reperfusion injury. At both the transcript and protein 
levels, however, CR, which is strongly expressed in several types of amacrine, ganglion, and displaced amacrine cells in both 
normal and affected retinas, was decreased. CR-expressing ganglion cell number was particularly decreased in ischemic 
retinas. Similar to the CR, PV transcript and protein levels, and PV-expressing AII amacrine cell number were decreased. 
Interestingly, in ischemic retinas PV was transiently expressed in putative cone bipolar cell types possibly those that connect 
with AII amacrine cells via gap junctions. These results suggest that these three calcium binding proteins may play different 
neuroprotective roles in ischemic insult by their ability to buffer calcium in the rat retina.
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in various neurodegenerative processes including ischemia. 
During cerebral ischemia, a series of biochemical events 
occur that causes depolarization, activation of voltage-gated 
Ca
2＋-channels and an excessive release of excitatory amino 
acids, especially glutamate. Activation of glutamate receptors 
leads to an increase in intracellular Ca
2＋ and the activation of 
Ca
2＋-dependent catabolic enzymes such as phospholipases, 
protein kinases, proteases, and caspase cascades (White et al., 
2000), which subsequently induce neuronal cell death. Past 
Introduction
Excessive calcium (Ca
2＋) is thought to be a critical step CaBP expression in ischemic rat retina
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exploration of this complex pathophysiology has resulted 
in the development of a large number of candidates for 
neuroprotective intervention. It is noteworthy that a number 
of Ca
2＋-channel blockers have been developed and tested for 
use in ischemic stroke treatment. However, they have failed 
in clinical trials because of either a lack of therapeutic efficacy 
or drastic side effects (Azcona & Lataste, 1990; Limburg & 
Hijdra, 1990; Rosenbaum  et al., 1991; Ahmed  et al., 1996).
Calcium binding proteins (CaBPs) are thought to play a 
major role in buffering intracellular Ca
2＋ and to be involved 
in a variety of Ca
2＋-mediated signal transduction (Rogers 
1987; Polans  et al., 1996; Schäfer & Heizmann, 1996). Three 
CaBPs, namely, calbindin D28k (CB), parvalbumin (PV) and 
calretinin (CR), members of the EF-hand calcium-binding 
protein family, have been implicated to play a neuroprotective 
role in various pathologic conditions by functioning as buffers 
for excessive calcium. In particular, CB is found in neurons 
throughout the central nervous system (Celio et al., 1990; 
Baimbridge  et al., 1992; Lewit-Bentley & Réty, 2000) and 
reactive astrocytes in some pathologic conditions (Toyoshima 
et al., 1996; Lee  et al., 2004), and has the ability to buffer and 
modulate intracellular Ca
2＋ concentrations (Batini et al., 1993 
and 1997). In addition, it has been reported that exogenous 
CB can reduce oxidative stress, preserve mitochondrial 
function and protect neurons against glutamate- or ischemia-
induced excitotoxicity (Guo et al., 1998; Meier  et al., 1998; 
D'Orlando et al., 2001 and 2002). However, relatively limited 
information concerning the neuroprotective function of CR 
and PV is available.
Although there are some differences in expression patterns 
among the species, CaBPs are expressed in specific neurons in 
the mammalian retina, as in other regions of the brain. Thus, 
anti-CaBPs have been used as markers for specific neuronal 
populations and/or subpopulations. In the rat retina, anti-
CB can be used to label horizontal cell population and 
subpopulations of amacrine and ganglion cells (Pasteels et al., 
1990; Chun et al., 1999). CR and PV are used to label different 
subsets of amacrine and ganglion cells (Pasteels et al., 1990; 
Sanna et al., 1990; Mojumder et al., 2008; Park et al., 2008). 
Using differential labeling with anti-CaBPs, specific retinal 
neurons have been characterized in both normal and various 
pathologic conditions.
Retinal ischemia induced by increasing intraocular 
pre  ssure has been widely used to examine the effects 
of ischemic damage, which leads to cellular changes in 
a variety of bioactive molecules in the retina including 
neurotransmitters and CaBPs, as well as changes in retinal 
neuronal populations or subpopulations. Using the real-
time quantitative polymerase chain reaction (PCR) (Dijk et 
al., 2004) and immunohistochemistry (Dijk & Kamphuis, 
2004), Kamphuis and co-workers reported that the transcript 
levels of PV and CR were decreased and the number of 
each expressing amacrine subpopulation was substantially 
reduced in the rat retina after ischemia/reperfusion insults. 
Using immunohistochemistry, Kwon et al. (2005) reported 
that CB-expressing ganglion cells were more resistant to 
ischemic damage than CR- and PV-expressing ganglion 
cells in the rabbit retina. These results suggest that CaBPs 
appear to be related to a differential vulnerability among 
retinal neurons to ischemic damage probably due to their 
different Ca
2＋ buffering abilities. At this point, in order 
to confirm previously reported results and to extend our 
knowledge related to the neuroprotective function of CaBPs 
and the vulnerability of retinal neurons to ischemic insult 
in the retina, we investigated changes in the expression of 
three calcium binding proteins, CB, PV and CR in ischemic 
rat retina induced by increasing intraocular pressure, at 
the transcript and protein levels using quantitative real-
time reverse transcription (RT)-PCR, western blot and 
immunohistochemistry. 
 
Materials and Methods
Animals
Thirty-five adult female Sprague-Dawley rats weighing 
200~250 g were used in this study. The animals were treated 
according to the regulations of the Catholic Ethics Committee 
of the Catholic University of Korea, Seoul, which conform to 
the National Institute of Health (NIH) guidelines for the Care 
and Use of Laboratory Animals (NIH Publications No. 80-23) 
revised 1996. 
Induction of transient retinal ischemia and tissue 
preparation
Animals were anesthetized with 4% chloral hydrate (1 
mL/100 g body weight). The pupils were dilated with 1% 
tropicamide drops. The intraocular pressure (IOP) was 
increased to 90~120 mm Hg by cannulation of the anterior 
chamber with a 26-gauge needle connected to a hydrostatic 
pressure device, and the elevated IOP was maintained for 60 
min. The applied pressure of 90~120 mm Hg is in the range 
or slightly above the systemic systolic pressure in the normal Anat Cell Biol 43:218~229, 2010 Shin Ae Kim, et al 220
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rat (Büchi et al., 1991). Following removal of the cannula, 
recirculation was immediately initiated and the IOP decreased 
to normal values within 5 min. 
Animals were sacrificed by an overdose of chloral hydrate 
at different time points after reperfusion: 1, 3 days, 1, 2, 4, 
8 weeks (wks). The anterior segments of the eyeballs were 
removed. For real-time PCR and western blot analysis, retinal 
tissues were quickly dissected on an ice-cold plate, frozen on 
dry ice, and stored at －70
oC. For immunohistochemistry, the 
eyecups were fixed by immersion in 4% paraformaldehyde 
in 0.1 M phosphate buffer (PB, pH 7.4), for 2~3 h. Following 
fixation, the retinae were carefully dissected and transferred 
to 30% sucrose in PB, for 24 h at 4
oC. They were then frozen 
in liquid nitrogen, thawed, and rinsed in 0.01 M phosphate-
buffered saline (PBS, pH 7.4).
Isolation of total RNA
Frozen retinas were homogenized and then suspended in 
1 mL of TRIZOL reagent (Invitrogen, Calrsbad, CA).  The 
homogenized samples were incubated for 5 min at room 
temperature and 0.2 mL of chloroform was added to each 
sample. The sample tubes were shaken vigorously by hand 
for 15 seconds and then incubated at room temperature for 5 
minutes. The mixture was separated into a lower red, phenol-
chloroform phase, an interphase, and a colorless upper 
aqueous phase by centrifugation at 13,000 rpm, 4
oC for 15 
minutes. The aqueous phase was transferred to a new tube and 
0.5 mL of isopropyl alcohol added. After incubation for 10 
minutes at room temperature, the samples were centrifuged at 
13,000 rpm, 4
oC for 15 minutes. The RNA precipitate formed 
a gel-like pellet on the side and bottom of the tube. The RNA 
pellet was washed once with 75% ethanol, then air-dried 
and re-dissolved in 30 μL 0.1% DEPC water. Total RNA was 
quantitatively measured with UV/Vis spetrophotometry (ND 
1,000, Nanodrop, Wilmington, USA).
Reverse transcription 
A two microgram sample of total RNA from retinal tissues 
was reverse transcribed using a High Capacity RNA-to-cDNA 
Kit (Applied Biosystems, Foster City, CA) according to the 
manufacturer’s protocol. RNA template and 2X RT buffer 
and 20X Enzyme mix were incubated at 37
oC for 60 minutes, 
followed by heating at 95
oC for 5 minutes to stop the reaction, 
after which, the cDNA products were stored at 4
oC.
Quantitative real-time RT-PCR
Real-time RT-PCR was performed using a Rotor-Gene 
6000 System instrument and software (Corbett Research, 
NSW, Australia). The relative expression level of one 
housekeeping gene and three target genes was measured by 
the TaqMan
® Gene expression-based method. For the real-
time PCR analyses, we acquired gene-specific FAM dye-
labeled primer-probe pairs: TaqMan MGB probes (Applied 
Biosystems). In this case, the exact primer and probe 
sequences were not available from the manufacturer. The 
sequences and information on the primers are presented in 
Table 1, and the specificity of the primers was confirmed by a 
BLAST search.
PCR reactions were prepared in a final volume of 20 μL, 
with 2X TaqMan
® Gene expression Master mix (Applied 
Biosystems) and cDNA derived from 10 ng of input RNA on 
ice.
The cycling conditions were as follows: AmpliTaq 
activation at 95°C for 10 minutes (one cycle), denaturation 
at 95°C for 15 seconds and annealing/extension at 60°C for 1 
minute (50 cycles). All assays included a positive control and 
a no-template control. Each measurement was performed in 
duplicate and the threshold cycle (CT) was determined.
Statistical analysis
The CT value was determined per gene for each sample. 
The CT values were transformed to linear scale raw expression 
quantities using the Δ-CT method, and were calculated using 
the Excel software program. To compare gene expression 
between samples, the CT was normalized to an endogenous 
Table 1. Sequences of real-time RT-PCR primers used in this study
Gene Sequence
GAPDH
  NM_017008.2
rForward 5'-TGCATCCTGCACCACCAA-3'
rReverse 5'-TCCACGATGCCAAAGTTGTC-3'
Probe 5'-FAM-TGCTTAGCCCCCCTGGCCAAG
-TAMRA-3'
Calbindin 1
  (=CalbindinD28k) 
  NM_031984.2
rForward 5'-CGGATGGAGGGAAGCTGTAC-3'
rReverse 5'-GGTTGTGGCCACCAACTCTAG-3'
Probe 5'-FAM-ACAGATCTTGCCCTTATTCTCT-
CTGCTGGG-TAMRA-3'
Calbindin2
  NM_053988.1
Pre-designed TaqMan
® Gene Expression Assays : Assay
  ID- Rn00588816_m1
Parvalbumin
  NM_022499.2
Pre-designed TaqMan
® Gene Expression Assays : Assay
  ID - Rn00574541_m1CaBP expression in ischemic rat retina
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reference (GAPDH) and relative to a calibrator. Correlation 
of gene-expression analyses was performed by the Pearson 
linear correlation. P-values were considered to be significant 
if <0.05.
Western blot analysis
Western blot analyses were performed on retinal extracts 
that had been homogenized in 10 vol of 20 mM Tris-HCl, 
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 
0.5% sodium deoxycholate, 0.1% sodium dodeyl sulfate 
(SDS), 0.02% sodium azide, 1 mM PMSF, and 5 μg/mL 
leupeptin. Protein concentration in each sample was assayed 
by the Lowry method (Lowry et al., 1951; Peterson 1979) in 
duplicate and the results averaged. Duplicate sets of protein 
standards containing 0, 1, 3, 5, 10, 20, 40, or 60 μg bovine 
serum albumin (BSA) were assayed by the same method. 
The results were averaged and graphed to produce a linear 
equation that was used to estimate the protein contents 
of the retinal extracts. The optical density of each sample 
was measured at 660 nm, using a spectrometer (Spectronic 
20; Bausch and Lomb, Rochester, NY). Aliquots of tissue 
samples corresponding to 25 μg of total protein were heated 
at 100°C for 10 min with an equivalent volume of 2× sample 
buffer (containing 4% SDS and 10% mercaptoethanol) and 
loaded onto 12% polyacrylamide gels. The proteins were 
electrotransferred to a nitrocellulose membrane in Tris-
glycine-methanol buffer. The membrane was blocked for 
1 h at room temperature in a blocking solution containing 
5% nonfat dry milk, 0.1% Tween-20, and PBS (pH 7.4). The 
membrane was then incubated for 15 h at 4°C with primary 
antibodies in the blocking solution. The following primary 
antibodies were used in the western blot experiments; mouse 
monoclonal anti-CB (Sigma, St. Louis, MO; dilution 1 : 
10,000), rabbit polyclonal anti-CR (Millipore, Bedford, MA; 
dilution 1 : 100,000), mouse monoclonal anti-PV (Sigma; 
dilution 1 : 1,000), and mouse monoclonal anti-β-actin 
(Sigma; dilution 1 : 100,000) for a control. The membrane 
was rinsed three times with 0.05% Tween-20 in PBS for 10 
min each, followed by incubation for 1 h at room temperature 
in a 1 : 200 dilution of biotinylated donkey anti-mouse IgG 
or anti-rabbit IgG (Vector Laboratories, Burlingame, CA). 
The blot was washed three times for 10 min each and then 
processed for analysis using an enhanced chemiluminescence 
(ECL) detection kit (Amersham, Arlington Heights, IL).
Immunohistochemistry 
Retinal tissues were blocked in 10% donkey serum and 
incubated with primary and secondary antibody dilutions, 
prepared in 1% donkey serum in PB with 0.5% Triton X 100. 
Primary antibodies were incubated at 4°C for 5~7 d, and 
secondary antibodies were incubated at 4°C overnight. The 
antibodies were applied in immunohistochemistry, as follows; 
mouse monoclonal anti-CB (Sigma; dilution 1 : 1,000) and 
rabbit polyclonal anti-CB (Swant, Bellinzona, Switzerland; 
dilution 1 : 2,000), rabbit polyclonal anti-CR (Millipore; 
dilution 1 : 2,000), and mouse monoclonal anti-PV (Sigma; 
dilution 1 : 1,000). The tissues were washed in PB for 45 min 
(3×15 min), incubated in the presence of Cy3-conjugated 
donkey anti-mouse IgG or donkey anti-rabbit IgG (Jackson 
Immuno Research, West Grove, PA; dilution 1 : 100) for 2 h. 
After thoroughly washing with PB, the retinal tissues were 
mounted with Vectashiled H-1000 (Vector Laboratories).
Digital images (1,024×1,024 pixels) were acquired using 
a Zeiss LSM 510 Meta confocal microscope (Carl Zeiss Co., 
Ltd., Germany). Images were converted into TIFF format, and 
processed for contrast level adjustment using Photoshop v. 7.0 
(Adobe Systems, San Jose, CA).
Cell number counting 
The number of the labeled cells was counted in five retinal 
wholemount peices of each group using an image analysis 
system Image-Pro Plus (I-CUBE, Glen Burnie, MD) and 
represented as the density (given in cells/mm
2). Using a 
20× objective and 10× eyepieces, images of 10 sample fields 
Fig. 1. Expression levels of calbindin (CB), calretinin (CR), and 
parvalbumin (PV) transcripts after ischemia/reperfusion injury in the 
rat retina. Error bars indicate standard deviation. *P<0.05; Student’s t 
test.Anat Cell Biol 43:218~229, 2010 Shin Ae Kim, et al 222
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per retina were captured and then processed. The density is 
described as mean±SD. 
Results
Changes of CB, CR and PV transcript levels
To examine changes in the expression of the three calcium 
binding proteins, CB, CR, and PV, in ischemic rat retina 
induced by increasing intraocular pressure, quantitative real-
time RT-PCR was performed at each time point. Following 
ischemia/reperfusion, changes in CB, CR and PV transcripts 
levels showed differential patterns (Fig. 1). 
CB transcript levels showed a reduction (on average 75%) 
from 1 day to 1 wk after ischemia/reperfusion; thereafter, the 
levels fluctuated. At 2 wks, a maximum was reached at 114% 
of the control level, the levels reverted to 93% at 4 wks, and 
at 8 wks, the level had increased to 112%. However, these 
changes during the latter half of the experimental period was 
statistically insignificant (Fig. 1, P>0.05).
Following ischemia/reperfusion, a gradual decrease in CR 
Fig. 2. Expression levels of CB, CR, and PV proteins after ischemia/
reperfusion injury in the rat retina. In the upper panel, Western 
blottings with CB (A), CR (B), and PV (C) antibodies demonstrate 
a single band at a molecular weight of 28-kDa, 29-kDa, and 12-kDa, 
respectively. Lower panel shows the results of densitometric analyses of 
Western blots shown in the upper panel.CaBP expression in ischemic rat retina
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transcript levels was observed from 1 day onward; at 1 wk, 
the value reached 42%. At 2 wks, the level rebounded and 
increased to 110%; thereafter the levels continued to decrease, 
finally reaching 37% of the control transcript level remaining 
(Fig. 1, P<0.05). 
The pattern of changes in transcript levels for PV was quite 
similar to that of CR (Fig. 1). Two differences were observed. 
One was an initial increase in PV transcript. The level reached 
108% of the control level, but was statistically insignificant 
(P>0.05). The other change was a significant peak at 2 wks 
(P<0.05). In the long term (4 and 8 wks after ischemia/
reperfusion), the transcript levels were significantly lower by 
71% and 50% of the control transcript level remaining (Fig. 1, 
P<0. 05).
Changes of CB, CR and PV protein levels by Western 
blot
The expression of CB, CR, and PV proteins was easily 
detectable in control retinas (Fig. 2). CB, CR and PV were 
detected as a single band at a 28-kDa, 29-kDa, and 12-kDa 
band, respectively. Following ischemia/reperfusion, the 
expression patterns of CB, CR and PV proteins were quite 
different among the three proteins. 
Compared to the control level, the levels of the CB protein 
did not changed significantly in response to ischemia/
reperfusion throughout the experimental period (Fig. 2A). 
The level of expression of CR began to decrease by 1 wk 
after ischemia/reperfusion and continued to be low thereafter. 
At 8 wks after ischemia/reperfusion, the protein level was 
significantly lower at 54% of the control level remaining (Fig. 
2B). 
In response to ischemia/reperfusion, the levels of PV 
protein rapidly decreased by 1 wk and reached a minimum of 
29% of the control level. Thereafter, the expression recovered, 
reaching 97% at 2 wks. Afterwards, the PV protein levels 
again rapidly decreased, reaching 32% of the control level at 8 
wks. 
Changes in CB, CR and PV-expressing retinal 
neurons by immunohistochemistry
Although CB is distributed in horizontal, amacrine 
and ganglion cells in the rat retina, it is strongly expressed 
in horizontal cells and thus has been used as a horizontal 
cell marker (Pasteels et al., 1990; Chun et al., 1999). In 
Fig. 3. Changes in the number of CB-expressing neurons after ischemia/reperfusion injury in the rat retina. A~C: confocal micrographs taken 
from vertical vibratome sections (40-μm-thick) of the normal rat retina (A) and retinas at 4 wks (B), and 8 wks (C) after ischemia/reperfusion 
injury, processed for CB immunoreactivities. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform 
layer; GCL, ganglion cell layer. Scale bar, 50 μm. D, E: confocal micrographs taken from wholemounts of the normal rat retina (D) and retina 
8 wks (E) after ischemia/reperfusion, processed for CB immunoreactivities. The figures (5 μm-thick) were formed by stacking optical sections 
focusing on the OPL to the outer part of the INL. Scale bar, 50 μm. F: quantitative assessment of the number of CB-expressing horizontal cells 
per mm
2 in normal retina (CTR) and retinas at 1 wk, 4 wks and 8 wks after ischemia/reperfusion injury. Error bars indicate standard deviation. 
*P<0.05; Student’s t test.Anat Cell Biol 43:218~229, 2010 Shin Ae Kim, et al 224
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vertical sections of control retina (Fig. 3A), strong CB 
immunoreactivities were found in horizontal cell somata 
in the outer part of the inner nuclear layer (INL) and their 
dendrites in the outer plexiform layer (OPL) and very faint 
immunoreactivities were observed in the inner part of the 
INL, inner plexiform layer (INL), and ganglion cell layer 
(GCL). These labeling pattern and number of CB-expressing 
cells appeared to be unchanged throughout the experimental 
period at a glance (Figs. 3B and C). These findings were 
clearly demonstrated in retinal whole mount preparations 
(Figs. 3D and E) and wereconfirmed by counting the CB-
expressing horizontal cells (Fig. 3F). 
CR immunoreactivities were found in numerous amacrine 
cells in the inner part of the INL and numerous cells in the 
GCL, and three bands in the IPL in the control retina (Fig. 
4A). The number of CR-expressing cells located in both the 
INL and GCL decreased with passing time (Figs. 4B and C). 
In particular, a marked decrease was observed in cells in the 
GCL (Figs. 4D and E). Compared to the cells of the GCL in 
the control retina, 67% were present in the retina at 4 wks 
after ischemia/reperfusion injury, and only 27% remained at 8 
wks (Fig. 4F). 
In the rat retina, PV is mainly expressed in AII amacrine 
cells in the INL and ganglion cells in the GCL in the minority, 
and thus anti-PV has been used as a marker for AII amacrine 
cells (Chun et al., 1993; Wässle et al., 1993). In the control 
retina, PV immunoreactivities were found in AII amacrine 
cells in the inner part of the INL and several ganglion cells in 
the GCL, and AII processes in the IPL (Fig. 5A). The numbers 
of PV-expressing AII amacrine cells and ganglion cells were 
gradually decreased (Figs. 5B~F). In retinal wholemounts 
at 8 wks after ischemia/reperfusion injury (Fig. 5H), 56% 
remained (Fig. 5I), compared to PV-expressing AII amacrine 
cells in the control retina (Fig. 5G). Interestingly, a new PV-
expressing population, presumably cone bipolar cells was 
transiently observed in the outer part of the INL. These 
cells were found between 3 days and 2 wks after ischemia/
reperfusion injury (Figs. 5B~D), with a peak at 3 days (Fig. 
5B). 
Discussion
Retinal ischemia/reperfusion can be a feature of patho-
logies such as amaurosis fugax and acute angle-closure 
Fig. 4. Changes in the number of CR-expressing neurons after ischemia/reperfusion injury in the rat retina. A~C: confocal micrographs taken 
from vertical vibratome sections (40-μm-thick) of the normal rat retina (A) and retinas at 4 wks (B), and 8 wks (C) after ischemia/reperfusion 
injury, processed for CR immunoreactivities. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform 
layer; GCL, ganglion cell layer. Scale bar, 50 μm. D, E: confocal micrographs taken from wholemounts of the normal rat retina (D) and retina 
8 wks (E) after ischemia/reperfusion, processed for CR immunoreactivities. The figures (8 μm-thick) were formed by stacking optical sections 
throughout the GCL. Scale bar, 50 μm. F: quantitative assessment of the number of CR-expressing ganglion cells per mm
2 in normal retina (CTR) 
and retinas at 1 wk, 4 wks and 8 wks after ischemia/reperfusion injury. Error bars indicate standard deviation. *P<0.05; Student’s t test.CaBP expression in ischemic rat retina
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glaucoma, and animal models have been used to study the 
mechanisms and effects of ischemic damage in the retina 
(Büchi et al., 1991; Kim et al., 1998; Li et al., 2009). Excessive 
Ca
2＋ is thought to be an important trigger, ultimately leading 
to ischemic neuronal degeneration (Kristián et al., 1998). 
CaBPs are thought to play a neuroprotective role in many 
pathologic conditions leading to neurodegeneration, by 
buffering excessive Ca
2＋. Thus, an impaired regulation of 
calcium by CaBPs is thought to be closely related to many 
neurodegenerative processes (Heizmann & Braun, 1992; 
Polans et al., 1996; Schäfer & Heizmann, 1996). Only a few 
studies have been reported dealing with changes in CaBPs 
after ischemia/reperfusion injury in the retina. However, 
most of these studies used CaBPs to identify specific retinal 
neuronal populations in a simple manner and the major focus 
was on the differential effects of ischemia/reperfusion injury 
on various retinal neuronal populations (Dijk et al., 2004; 
Dijk & Kamphuis, 2004; Kwon et al., 2005). In addition, the 
duration of the observations was relatively short (4 wks after 
ischemia/reperfusion injury). In the present study, therefore 
we examined the changes in both transcripts and proteins of 
three EF-hand CaBPs, CB, CR and PV, which are abundantly 
expressed in specific neurons of the mammalian retina, over 
a long period of time (Pasteels et al., 1990; Sanna et al., 1990;   
Wässle et al., 1993; Chun et al., 1999; Mojumder et al., 2008; 
Park  et al., 2008), in rat retina induced ischemia/reperfusion 
injury produced by raising the intraocular pressure.
After ischemia/reperfusion retinal neurons in the GCL 
Fig. 5. Changes in the number of PV-expressing neurons after ischemia/reperfusion injury in the rat retina. A~F: confocal micrographs 
taken from vertical vibratome sections (40-μm-thick) of the normal rat retina (A) and retinas at 3 days (B), 1 wk (C), 2 wks (D), 4 
wks (E), and 8 wks (F) after ischemia/reperfusion injury, processed for PV immunoreactivities. Arrows indicate a new PV-expressing 
population. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion 
cell layer. Scale bar, 50 μm. G, H: confocal micrographs taken from wholemounts of the normal rat retina (G) and retina 8 wks (H) 
after ischemia/reperfusion, processed for PV immunoreactivities. The figures (8 μm-thick) were formed by stacking optical sections 
throughout the GCL. Scale bar, 50 μm. I: quantitative assessment of the number of PV-expressing AII amacrine cells per mm
2 in 
normal retina (CTR) and retinas at 1 wk, 4 wks and 8 wks after ischemia/reperfusion injury. Error bars indicate standard deviation.   
* P<0.05; Student’s t test.Anat Cell Biol 43:218~229, 2010 Shin Ae Kim, et al 226
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and INL undergo cell death via necrosis and apoptosis, and 
subsequently photoreceptors in the ONL (Büchi 1992a and 
1992b; Choi 1996 and 2001; Kim et al., 2004). Despite the 
marked loss of retinal neurons, CB transcript and protein 
levels were not significantly changed in response to ischemia/
reperfusion throughout the entire experimental period in this 
study. In addition, most of the CB-expressing horizontal cells 
had survived at the end of experimental period. These results 
are consistent with our previous immunohistochemical study 
(Chun et al., 1999) showing that horizontal cells labeled with 
anti-CB are resistant to degenerative processes to ischemic 
damage in the rat retina. These conclusions were also verified 
by Kwon et al. (2005) who reported that CB-immunnoreactive 
cells in the GCL of the rabbit retina were less vulnerable than 
CR- or PV-immunoreactive neurons. The expression of CB 
was increased in transient forebrain ischemia (Hwang et al., 
2003) and spinal ischemia (Lee et al., 2005), which appeared 
to be related to resistance to neuronal degeneration. An over-
expression of CB protected neuronal cells from signals that 
increase intracellular Ca
2＋ and induce apoptosis and thus 
could decrease neuronal death after transient focal ischemia 
(Yenari et al., 2001). In addition, Fan et al. (2007) recently 
demonstrated that CB protein transduction can significantly 
decrease neuronal death in cultures and an animal model of 
cerebral ischemia. Collectively, these findings indicate that CB 
might play a role in neuroprotection to ischemia/reperfusion 
injury in the retina and CB-expressing horizontal cells appear 
to have such resistance.
In contrast to CB, transcripts and proteins of CR and 
PV were decreased after ischemia/reperfusion in this study. 
At 8 wks after ischemia/reperfusion, the numbers of CR-
expressing cells in the GCL and PV-expressing cells were 
only 27% and 56% of the control group, respectively. These 
results are consistent with previous reports by Kamphuis and 
co-workers (Dijk et al., 2004; Dijk & Kamphuis, 2004) who 
reported that transcripts and expressing cell numbers of CR 
and PV were decreased at 4 wk after ischemia/reperfusion. In 
terms of vulnerabilities of CR and PV in response to ischemia/
reperfusion, however, our results were in conflict with their 
reports. In this study, among the three CaBPs, CR-expressing 
cells appeared to be the most vulnerable, while PV-expressing 
cells were identified as the most vulnerable ones in their 
study (Dijk & Kamphuis, 2004). This discrepancy might be 
caused by the differences in the ischemia/reperfusion injury 
model. That is, Dijk and Kamphuis used Wistar rats and 
induced retinal ischemia by increased intraocular pressure 
(IOP) using a 30-gauge needle connected to a saline reservoir, 
elevated to 1.7 m (Dijk & Kamphuis, 2004), while we used 
Sprague-Dawley rats and induced ischemia by increasing IOP 
using a 26-gauge needle connected to a hydrostatic pressure 
device, raised to 90~120 mm Hg. Although the difference 
in ischemia/reperfusion injury model appears to be minor, 
it should be recalled that a minor difference can cause quite 
different ischemic insults. For example, one of the cerebral 
ischemia models, the four vessel occlusion model using 
Wistar rats causes white matter degeneration in the brain, 
while that using Sprague-Dawley rats show hippocampal 
degeneration (Kim et al., 2008). Actually, the INL, IPL, and 
GCL were distinguishable at 4 and 8 wks after ischemia/
reperfusion in this study (Figs. 3~5), while in the report 
by Dijk and Kamphuis (Dijk & Kamphuis, 2004), the IPL 
already appeared markedly thinned at 72 h and thus at 1 wk 
or 2 wks the IPL appeared a sheet. These results indicate that 
the ischemia/reperfusion injury in our model is milder than 
that of Dijk and Kamphuis (Dijk & Kamphuis, 2004) and at 
least in our retinal ischemia/reperfusion injury model, CR-
expressing cells might be the most vulnerable. 
Interestingly, a great decrease in CR-expressing ganglion 
cells occurred near the end of the study period, that is, from 
67% of control at 4 wks to 27% at 8 wks (Fig. 4F). Considering 
that the retinal ganglion cell is the most vulnerable cell type 
in some pathologic conditions, such as glaucoma, retinal 
ischemia, and NMDA toxicity (Perlman et al., 1996; Adachi 
et al., 1998; Joo et al., 1999; Kageyama et al., 2000), our results 
suggest that CR may act as a Ca
2＋ buffer in CR-expressing 
ganglion cells, preventing them from degeneration and 
contribute to their survival from initial ischemia/reperfusion 
injury during the first half of an experimental period. In 
contrast to CR-expressing ganglion cells, PV-expressing AII 
amacrine cells were more decreased in the first half of the 
experimental period (27% reduction by 4 wks) than in the 
latter half (17% reduction) (Fig. 5F). CaBPs are thought to 
be involved in various Ca
2＋-mediated signal transduction 
processes in the central nervous system, in addition to 
buffering intracellular Ca
2＋ (Rogers 1987;  Polans et al., 1996; 
Schäfer & Heizmann, 1996). Although the functions of other 
CaBP, including PV in the retina, remain unclear, our results 
suggest that PV may act as a mediator that is involved in some 
currently not understood Ca
2＋-mediated signal transduction 
within PV-expressing AII amacrine cells rather than acting as 
a Ca
2＋ buffer. The functions of CaBPs including PV need to 
be elucidated through the further studies. CaBP expression in ischemic rat retina
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Another interesting finding of this study is that a new PV-
expressing neuronal population transiently appeared during 
the period 3 days to 2 wks. In the rat retina, PV is mostly 
highly expressed in AII amacrine cells, a crucial interneuron 
in the rod pathway, in the INL and thus, anti-PV has been 
used as a marker for AII amacrine cells (Chun et al., 1993; 
Wässle et al., 1993). These AII amacrine cells make extensive 
gap junctions with some types of ON cone bipolar cells 
(Massey &  Mills, 1996 and 1999). Gap junctions generally 
transport molecules with molecular weights of below 1 kD 
in physiological conditions (Flagg-Newton et al., 1979). 
However, it has been demonstrated that the permeability of 
this gap junction can be altered in response to modulators 
such as dopamine and nitric oxide (Vaney et al., 1998; Xia & 
Mills, 2004). In addition, Park et al. (2008) recently reported 
the same phenomenon, in that a new group of PV-expressing 
cells was transiently found in the outer part of the INL in the 
rat retina experimentally induced diabetes and, using double-
labeling technique, they demonstrated that they were the type 
6 ON cone bipolar cells. Although we did not characterize the 
new population of PV-expressing cells in this study, therefore, 
it appears likely that this new population of PV-expressing 
cells in the INL are a certain type of ON cone bipolar cells 
and this transient expression of PV in some cone bipolar cells 
might be derived from an altered permeability, caused by 
ischemia/reperfusion injury, and not by de novo synthesis. 
In conclusion, CB among the three CaBPs studied in this 
study, may have a neuroprotective function to ischemia/
reperfusion injury through its powerful ability to buffer 
increased Ca
2＋ in the rat retina, and CR may provide some 
resistance to ischemia/reperfusion to CR-expressing ganglion 
cells but not as much as CB. In addition, PV may mainly act 
as a mediator involved in some type of Ca
2＋-mediated signal 
transduction within PV-expressing AII amacrine cells, rather 
than as a Ca
2＋ buffer. 
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